A review of clinical efficacy and safety of canagliflozin 300 mg in the management of patients with type 2 diabetes mellitus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A review of clinical efficacy and safety of canagliflozin 300 mg in the management of patients with type 2 diabetes mellitus

Published:2017 Issue:1 Volume:21 Page:196
ISSN:2230-8210
Container-title:Indian Journal of Endocrinology and Metabolism
language:en
Short-container-title:Indian J Endocr Metab

Author:

Garodia Nishant,Prasanna Kumar KM,Ghosh Sujoy,Canovatchel William,Rajashekar Sujith

Publisher

Medknow

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical effects of Sodium/glucose cotransporter-2 inhibitors in patients with type 2 diabetes;2023-11-29

2. Canagliflozin: metabolic, cardiovascular and renal protection;Future Cardiology;2021-05

3. Novel and emerging therapeutic drug targets for management of type 2 Diabetes Mellitus;Obesity Medicine;2021-05

4. Real world study of short term efficacy, safety, and tolerability of canagliflozin 100 mg initiation in type 2 diabetes mellitus patients during hot humid Indian summer;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2021-01

5. A real-world retrospective evaluation of glycaemic control and weight loss in patients with type 2 diabetes mellitus treated with canagliflozin 100 mg and canagliflozin 300 mg in an Indian setting;Clinical Diabetology;2020-11-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP